Thank you for your question.
I don't know enough about the regime you mentioned.
Nevertheless, generally speaking, the Global Fund partnership is an excellent tool, because we can sit down with the board and talk about which tools are working and which ones aren't as effective in relation to implementing countries. Those partners can also help us adjust our mechanisms.
I don't know the situation with the specific regime you brought up, but on our end, we have set up something I think is very useful, the pooled procurement mechanism. Through the mechanism, we are able to provide high-quality medicines to the countries we invest in and support, to prevent the use of counterfeit drugs or products that do not meet the necessary quality standards. Of course, the mechanism also gives us the ability to negotiate prices. The Global Fund's scope of activity gives us some influence so that we can bring down prices, whether for AIDS, tuberculosis or malaria drugs, or COVID‑19 antigen tests.
Our pooled procurement mechanism makes it easier to access quality-assured medicines at lower prices. As mentioned earlier, it also helps mitigate corruption risks in the supply chain.